PL2670737T3 - Sposób wytwarzania metaksalonu - Google Patents

Sposób wytwarzania metaksalonu

Info

Publication number
PL2670737T3
PL2670737T3 PL12700288T PL12700288T PL2670737T3 PL 2670737 T3 PL2670737 T3 PL 2670737T3 PL 12700288 T PL12700288 T PL 12700288T PL 12700288 T PL12700288 T PL 12700288T PL 2670737 T3 PL2670737 T3 PL 2670737T3
Authority
PL
Poland
Prior art keywords
metaxalone
preparation
Prior art date
Application number
PL12700288T
Other languages
English (en)
Inventor
Tommaso Iacoangeli
Mario Chiavarini
Antonello Fazio
Marcello Marchetti
Giovanni Battista Ciottoli
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of PL2670737T3 publication Critical patent/PL2670737T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL12700288T 2011-02-01 2012-01-17 Sposób wytwarzania metaksalonu PL2670737T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11152849 2011-02-01
US201161439127P 2011-02-03 2011-02-03

Publications (1)

Publication Number Publication Date
PL2670737T3 true PL2670737T3 (pl) 2017-02-28

Family

ID=44115617

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12700288T PL2670737T3 (pl) 2011-02-01 2012-01-17 Sposób wytwarzania metaksalonu

Country Status (26)

Country Link
US (2) US20130261160A1 (pl)
EP (1) EP2670737B1 (pl)
JP (1) JP2014503564A (pl)
KR (1) KR101907599B1 (pl)
CN (1) CN103298797B (pl)
AR (1) AR084946A1 (pl)
AU (1) AU2012213666B2 (pl)
BR (1) BR112013013134B1 (pl)
CA (1) CA2817462C (pl)
CY (1) CY1118348T1 (pl)
DK (1) DK2670737T3 (pl)
EA (1) EA024417B1 (pl)
ES (1) ES2605425T3 (pl)
GE (1) GEP20156352B (pl)
HR (1) HRP20161660T1 (pl)
HU (1) HUE029476T2 (pl)
IL (1) IL226329A (pl)
LT (1) LT2670737T (pl)
MX (1) MX339346B (pl)
PL (1) PL2670737T3 (pl)
PT (1) PT2670737T (pl)
SG (2) SG10201600357WA (pl)
SI (1) SI2670737T1 (pl)
SM (1) SMT201600415B (pl)
UA (1) UA114593C2 (pl)
WO (1) WO2012104139A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102181881B1 (ko) 2014-11-21 2020-11-24 삼성디스플레이 주식회사 비전 검사 장치 및 이의 감마 및 얼룩 보정 방법
EP4703401A1 (en) * 2023-04-28 2026-03-04 Toray Industries, Inc. Epoxy resin composition, prepreg, fiber-reinforced composite material, and method for producing epoxy resin composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1487641A (fr) 1965-07-24 1967-07-07 Henkel & Cie Gmbh Procédé de préparation d'oxazolidones substituées
DE1545951A1 (de) * 1965-07-24 1970-05-14 Henkel & Cie Gmbh Verfahren zur Herstellung von substituierten Oxazolidonen
WO2003061552A2 (en) * 2002-01-14 2003-07-31 Sun Pharmaceutical Industries Limited Novel process for the preparation of substantially pure 5-(3,5-dimethylphenoxy)methyl-2-oxazolidinone
US6562980B1 (en) 2002-08-19 2003-05-13 Yung Shin Pharma Ind. Co., Ltd. Method for producing 5-aryloxymethyl-2-oxazolidinones
WO2007074477A2 (en) * 2005-12-29 2007-07-05 Dabur Pharma Limited Metaxalone polymorphs
WO2008006096A1 (en) * 2006-07-07 2008-01-10 Boehringer Ingelheim Chemicals, Inc. Metaxalone synthesis
CN101921241A (zh) * 2009-06-12 2010-12-22 北京京卫燕康药物研究所有限公司 具有光学活性的美他沙酮的合成

Also Published As

Publication number Publication date
JP2014503564A (ja) 2014-02-13
BR112013013134B1 (pt) 2021-06-08
ES2605425T3 (es) 2017-03-14
MX339346B (es) 2016-05-20
CN103298797A (zh) 2013-09-11
US20130261160A1 (en) 2013-10-03
GEP20156352B (en) 2015-08-25
AU2012213666B2 (en) 2016-09-08
EA024417B1 (ru) 2016-09-30
CA2817462C (en) 2019-03-19
IL226329A (en) 2017-12-31
UA114593C2 (uk) 2017-07-10
SMT201600415B (it) 2017-01-10
SG192090A1 (en) 2013-08-30
AR084946A1 (es) 2013-07-10
BR112013013134A2 (pt) 2016-08-23
HRP20161660T1 (hr) 2017-01-13
CA2817462A1 (en) 2012-08-09
PT2670737T (pt) 2016-11-08
US9416116B2 (en) 2016-08-16
EP2670737B1 (en) 2016-09-14
HK1191006A1 (zh) 2014-07-18
EP2670737A1 (en) 2013-12-11
EA201390787A1 (ru) 2013-11-29
MX2013008426A (es) 2013-09-13
HUE029476T2 (en) 2017-02-28
KR20140000705A (ko) 2014-01-03
LT2670737T (lt) 2016-12-12
KR101907599B1 (ko) 2018-10-12
AU2012213666A1 (en) 2013-05-30
DK2670737T3 (en) 2016-12-19
US20150284345A1 (en) 2015-10-08
SI2670737T1 (sl) 2016-12-30
WO2012104139A1 (en) 2012-08-09
IL226329A0 (en) 2013-07-31
CN103298797B (zh) 2016-04-20
CY1118348T1 (el) 2017-06-28
SG10201600357WA (en) 2016-02-26

Similar Documents

Publication Publication Date Title
GB201110095D0 (en) Method of treatment
EP2773754A4 (en) Methods of Treatment
ZA201305972B (en) Method for the preparation of biphephos
PT2665728E (pt) Método de preparação de um intermediário de sitagliptina
SG11201400939YA (en) Process for the preparation of methoxymelonal
EP2663568A4 (en) PROCESS FOR THE PREPARATION OF ACETALS
GB201810013D0 (en) An improved method of preparing buprenorphine
ZA201302020B (en) Process for preparation of rilpivirine intermediate
SG2014010441A (en) Preparation process of l-methionine
EP2668260A4 (en) METHOD FOR MODIFYING BACTERIA
ZA201401492B (en) Method for ease of ironing
GB2494492C (en) Method of single point internal lock-mobility correction
EP2698159A4 (en) PITAVASTATE-CONTAINING PREPARATION AND METHOD OF MANUFACTURING THEREOF
IL226436A0 (en) Methods for the preparation of bendamustine
GB2496512B (en) Method of making cutter elements
EP2684869A4 (en) PREPARATION OF 3-MERCAPOTOPROPIONATES
PL2547683T3 (pl) Sposób wytwarzania Sitagliptyny
IL226329A0 (en) A method @ for preparation @ from a tax salon
GB201114798D0 (en) Method of modifying surfaces
GB201119607D0 (en) Method of manufacture
GB201102475D0 (en) Method of reducing offset
EP2751098A4 (en) PROCESS FOR THE IMPROVED PREPARATION OF ZOLMITRIPTAN
EP2791324A4 (en) PROCESSING METHOD
PL395425A1 (pl) Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu
PL2610371T3 (pl) Sposób otrzymywania stopów ren - nikiel